Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-09 Paggiarino Dario A. Chief Medical Officer Grant or award · Restricted Stock Units +17,500 17,500
2022-02-09 Paggiarino Dario A. Chief Medical Officer Option exercise · Restricted Stock Units −4,966 9,934
2022-02-09 Paggiarino Dario A. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +70,000 70,000
2022-02-09 Jones David Scott SVP & Chief Commercial Officer Option exercise +4,966 14,097
2022-02-09 Jones David Scott SVP & Chief Commercial Officer Shares withheld for taxes −1,473 $10.13 $15K 12,624
2022-02-09 Jones David Scott SVP & Chief Commercial Officer Grant or award · Restricted Stock Units +15,000 15,000
2022-02-09 Jones David Scott SVP & Chief Commercial Officer Option exercise · Restricted Stock Units −4,966 9,934
2022-02-09 Jones David Scott SVP & Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +60,000 60,000
2022-02-09 Lurker Nancy President & CEO Option exercise +17,533 124,098
2022-02-09 Lurker Nancy President & CEO Option exercise · Restricted Stock Units −17,533 35,067
2022-02-09 Lurker Nancy President & CEO Grant or award · Restricted Stock Units +60,000 60,000
2022-02-09 Lurker Nancy President & CEO Grant or award · Stock Option (Right to Buy) +240,000 240,000
2022-01-10 Pine Michael Craig Chief Corp Dev.&Strat. Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2021-11-15 Lurker Nancy President & CEO Sale −10,000 $20.15 $201K 103,546
2021-11-01 Duker Jay S. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +239,700 239,700
2021-11-01 Jones David Scott SVP & Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-11-01 Duker Jay S. Chief Operating Officer Grant or award · Restricted Stock Units +15,258 15,258
2021-11-01 Duker Jay S. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +305,000 305,000
2021-06-22 Godshall Douglas Evan Director Option exercise +2,500 8,016
2021-06-22 Godshall Douglas Evan Director Option exercise · Restricted Stock Units +2,500 0

Page 29 of 31 · 616 trades